THOMAS MCINNIS: Open Payments
NPI 1528747300 · NEENAH, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$205 in 11 payments from 9 companies in 2025. Trend: 2023 $70 · 2024 $436 · 2025 $205
Food & beverage: $205
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 2 | $39 |
| E.R. Squibb & Sons, L.L.C. | 2 | $31 |
| Alnylam Pharmaceuticals Inc. | 1 | $25 |
| Edwards Lifesciences Corporation | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| Amgen Inc. | 1 | $19 |
| GENZYME CORPORATION | 1 | $18 |
| United Therapeutics Corporation | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
Products named: ELIQUIS, ONPATTRO, CARDIOMEMS, SAPIEN 3 Ultra RESILIA, VERQUVO, REPATHA, FABRAZYME, Tyvaso.
Industry payments across WI — which companies pay providers there.
